Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
BAC : I see a gradual run to $32 before it levels. Nothing really holding it back, but some profit takers if they choose to sell. The news has been brisk and inviting for investors for the time period.
Bank of America Corporation (BAC)
NYSE - $27.16
https://finance.yahoo.com/quote/BAC/
OPINION
You maybe very close to being correct. I see a gradual run to $32 before it levels. Nothing really holding it back, but some profit takers if they choose to sell. The news has been brisk and inviting for investors for the time period.
My Opinion.
So far the main financial source on a consistent historical pattern has been dilution. Presently the shares are headed for another reverse split, if so ordered to keep their exchange listing. Time and share price are ticking. Otherwise the business growth pattern is exceedingly well. The financial growth pattern though has not correlated to pay for operating expenses. When that finally occurs. That will make a difference between this company being an investment POS or a profitable growth value investment.
Noted: I still do not own any shares presently.
You ain't seen nothin' yet! [Symbol EGHT!]
Anders Bylund (8x8): If you want to match Costco's extraordinary returns starting from the early 1980s, you have to start with a small business, largely unknown, that isn't an obvious winner yet. In 1982, Costco had yet to open its first store and the Price Club merger that made it a public company was more than a decade ahead.
Enterprise communications specialist 8x8 is the closest I can get to that type of champing-at-the-bit early investment opportunity. Sure, the company has been around since 1987 and joined the public stock market way back in 2002, but the business opportunity in internet-based voice and video communications services feels fresh and almost entirely untapped, even now.
This company's services combine low cost and high quality, thanks to a lean, mean cloud-computing infrastructure. Business is going gangbusters. In the recently reported second quarter, revenues rose 15% year over year, with a 33% surge in service orders from mid-market and enterprise customers.
The company has formed several distribution and cross-selling partnerships, and R&D budgets are rising as fast as the top-line sales. To me, that combination signals a tech company that wants to hang around for the long haul. It's all about innovation and market growth.
8x8's products and services have been gaining traction in the marketplace in recent years, which is why sales and share prices are skyrocketing today. I'll admit that it will be tough to match Costco's legendary long-term returns, but 8x8 could come close.
Anders Bylund, Steve Symington, and Timothy Green, The Motley Fool
Motley FoolOctober 19, 2017
https://finance.yahoo.com/news/3-stocks-look-just-costco-214900772.html
Stock quote EGHT: https://finance.yahoo.com/quote/EGHT?p=EGHT
You ain't seen nothin' yet! [Symbol EGHT!]
Anders Bylund (8x8): If you want to match Costco's extraordinary returns starting from the early 1980s, you have to start with a small business, largely unknown, that isn't an obvious winner yet. In 1982, Costco had yet to open its first store and the Price Club merger that made it a public company was more than a decade ahead.
Enterprise communications specialist 8x8 is the closest I can get to that type of champing-at-the-bit early investment opportunity. Sure, the company has been around since 1987 and joined the public stock market way back in 2002, but the business opportunity in internet-based voice and video communications services feels fresh and almost entirely untapped, even now.
This company's services combine low cost and high quality, thanks to a lean, mean cloud-computing infrastructure. Business is going gangbusters. In the recently reported second quarter, revenues rose 15% year over year, with a 33% surge in service orders from mid-market and enterprise customers.
The company has formed several distribution and cross-selling partnerships, and R&D budgets are rising as fast as the top-line sales. To me, that combination signals a tech company that wants to hang around for the long haul. It's all about innovation and market growth.
8x8's products and services have been gaining traction in the marketplace in recent years, which is why sales and share prices are skyrocketing today. I'll admit that it will be tough to match Costco's legendary long-term returns, but 8x8 could come close.
Anders Bylund, Steve Symington, and Timothy Green, The Motley Fool
Motley FoolOctober 19, 2017
https://finance.yahoo.com/news/3-stocks-look-just-costco-214900772.html
Stock quote EGHT: https://finance.yahoo.com/quote/EGHT?p=EGHT
You ain't seen nothin' yet
Anders Bylund (8x8): If you want to match Costco's extraordinary returns starting from the early 1980s, you have to start with a small business, largely unknown, that isn't an obvious winner yet. In 1982, Costco had yet to open its first store and the Price Club merger that made it a public company was more than a decade ahead.
Enterprise communications specialist 8x8 is the closest I can get to that type of champing-at-the-bit early investment opportunity. Sure, the company has been around since 1987 and joined the public stock market way back in 2002, but the business opportunity in internet-based voice and video communications services feels fresh and almost entirely untapped, even now.
This company's services combine low cost and high quality, thanks to a lean, mean cloud-computing infrastructure. Business is going gangbusters. In the recently reported second quarter, revenues rose 15% year over year, with a 33% surge in service orders from mid-market and enterprise customers.
The company has formed several distribution and cross-selling partnerships, and R&D budgets are rising as fast as the top-line sales. To me, that combination signals a tech company that wants to hang around for the long haul. It's all about innovation and market growth.
8x8's products and services have been gaining traction in the marketplace in recent years, which is why sales and share prices are skyrocketing today. I'll admit that it will be tough to match Costco's legendary long-term returns, but 8x8 could come close.
Anders Bylund, Steve Symington, and Timothy Green, The Motley Fool
Motley FoolOctober 19, 2017
https://finance.yahoo.com/news/3-stocks-look-just-costco-214900772.html
8x8 Appoints Accomplished Industry Executives to Key Strategic Positions Overseeing Company’s Global Sales Organization
October 19, 2017
08:15 AM ETBusiness Wire
8x8 Inc
Latest round of senior leadership hires and promotions completes one of 8x8’s strategic investment initiatives to accelerate sales momentum and revenue growth
SAN JOSE, Calif.--(BUSINESS WIRE)-- 8x8, Inc. (NASDAQ:EGHT), the leading provider of truly unified communications, today announced the appointments of multiple senior executives to the company’s global sales organization. These appointments, combined with the recent strengthening of 8x8’s marketing and engineering organizations, align with the company’s strategic decision to increase its investment in the business to accelerate sales momentum and revenue growth.
“By assembling world-class sales, marketing and engineering teams, 8x8 is maximizing its ability to develop, market, sell and deliver the truly unified communications solutions and services that companies need on a global basis to run their business smarter and faster,” said Vikram Verma, CEO of 8x8. “These latest, high-caliber appointments to our global sales organization underscore the attractiveness of the $50 billion cloud communications market opportunity, and the leadership position 8x8 has earned in the industry. With our senior leadership team now fully in place, we look forward to implementing additional strategic initiatives to accelerate adoption and revenue growth globally across all of our core customer segments.”
As part of the announcement, 8x8 is realigning the company into two business units—Small Business & eCommerce and Midmarket & Enterprise. These two business units, led by new Senior Vice Presidents Samuel Wilson and Scott Sampson respectively, will align sales and delivery, tightly coupled with demand generation, services and support to drive segment revenue, growth and profitability globally. Senior Vice President of Global Sales Puneet Arora will remain at the company through the end of the calendar year to assist in the transition, and both Wilson and Sampson will report directly to 8x8 CEO Vikram Verma. Recent promotions and hires include:
Scott Sampson, Senior Vice President of Midmarket & Enterprise, is responsible for all efforts to expand global midmarket and enterprise sales with a focus on developing and leveraging channel relationships to help drive this consultative sales business. He has more than 25 years of software industry experience with a proven track record of sales success. Sampson was most recently the Chief Revenue Officer at New Voice Media where he had global responsibility for all the company’s sales, channel and marketing functions. He previously held sales executive and management positions at IBM, including Vice President of Worldwide Analytics Platform Sales, a multi-billion-dollar revenue business, and Vice President of Industry Cloud Solutions, North America. While at IBM, Sampson led organizations ranging in size from 150 to 4,000 sales professionals, and was consistently ranked in the top one percent of global sales leadership. Sampson has a B.S. in Computer Science from Northeastern University and an MBA from the Massachusetts Institute of Technology.
Samuel Wilson, Senior Vice President of Small Business & eCommerce, is responsible for all global small business and eCommerce sales, operations and delivery with an aim to accelerate growth and productivity in this high-volume, transactional business. He joins 8x8 from MobileIron where he was instrumental in taking the company public and part of the team that grew annual billings from $26 million to $200 million, including building and leading their eCommerce business. Prior to MobileIron, Wilson spent 14 years in technology banking, both as an analyst covering communications and as an institutional investor. Wilson has a B.S. in Electrical Engineering from Seattle University and an MBA from the University of California, Berkeley.
Rick Boyd, Vice President of North America Midmarket Sales, is responsible for driving customer success in the midmarket, and will work closely with 8x8 marketing and the channel to increase demand generation and sales execution efforts. He brings more than 25 years of selling and management experience to 8x8, and most recently served as Vice President of Client Sales Americas at ShoreTel, where he was responsible for midmarket and enterprise teams. Boyd previously held sales leadership positions at Verisign and Mitel.
Brendan Maree, Vice President of Asia Pacific Sales, is based in Sydney, Australia, and is responsible for expanding on 8x8’s initial success in Australia and New Zealand to grow the company’s presence within the Asia-Pacific region. He joins the company from Interactive Intelligence where he most recently served as Senior Vice President of Japan, Australia and New Zealand, helping the company dramatically increase revenue and market share in the region during his tenure. Maree formerly held sales leadership positions at IPL Communications, Mobile Coverage Solutions and Andrew Corporation.
Promoted to Vice President of North America Enterprise Sales, Kyle DiPentima is now responsible for accelerating growth of 8x8’s enterprise customer business in the U.S. He brings a successful track record of more than 20 years in enterprise sales experience, including previously leading 8x8’s Eastern Region enterprise sales team. Prior to 8x8, DiPentima held sales positions at LivePerson, Kontagent, Oracle, NICE Systems and Careerbuilder.com.
Promoted to Vice President of Europe, the Middle East and Africa (EMEA) Sales, Sharon Maslyn will continue to lead midmarket, enterprise and channel sales in the UK, and is now responsible for all sales efforts throughout Europe, the Middle East and Africa as 8x8 continues its global expansion. She has more than 20 years of sales management experience, and previously held leadership positions at DXI, Relaystation, Verizon and Pitney Bowes.
8x8 now delivers one unified platform for cloud communications, collaboration tools, video conferencing, and contact center solutions to improve IT efficiency and reduce headaches; one seamless communications experience for employees and customers; and one real-time data analytics platform for constant learning and improvement. The company recently launched 8x8 Virtual Office® Editions, a suite of products designed to revolutionize business communications. As part of the launch, 8x8 announced the new 8x8 Virtual Office X8 edition, which offers unified communications, collaboration and contact center in one solution. By eliminating the communications silos that exist due to fragmented solutions, 8x8 Virtual Office X8 allows companies to run their business faster and smarter with a unified solution for efficient and seamless communications and collaboration between employees, partners and customers.
About 8x8, Inc.
8x8, Inc. (NASDAQ:EGHT), the leading provider of truly unified communications, powers over a million business users worldwide. The 8x8 suite of products seamlessly weaves together cloud telephony, messaging, meetings and contact center solutions with a data analytics platform, helping modern organizations communicate at the speed of employee and customer expectations. 8x8 uniquely combines one unified management platform, one seamless communications experience for employees and customers, and one real-time data analytics platform for constant learning and improvement.
8x8® and 8x8 Virtual Office are trademarks of 8x8, Inc.
View source version on businesswire.com: http://www.businesswire.com/news/home/20171019005519/en/
8x8, Inc.
John Sun, 408-692-7054
john.sun@8x8.com
or
InkHouse for 8x8
Kelsey Miller, 415-299-6219
8x8@inkhouse.com
Source: 8x8
I cannot say never, but for now, no is the answer. I do not see a forward split in the near future. It is possible though.
You might be right, and buying into the recent dilution pollution. May very well absorb it. There is the possibility that after the dilution absorption. The share price may go higher in reflection of higher palladium prices.
Palladium Tops $1,000 for First Time Since '01 on Auto Catalysts
Bloomberg
Ranjeetha Pakiam
BloombergOctober 16, 2017
Palladium climbed above $1,000 an ounce for the first time since 2001 as demand grows for the metal in pollution-control devices for gasoline-powered vehicles.
The metal rose as much as 1 percent to $1,000.84 on Monday. Prices have advanced 47 percent this year, outperforming other precious metals, with gold increasing 14 percent, silver adding 9 percent and platinum up 4.7 percent.
The metal, used mostly in catalytic converters, is more expensive than its sister platinum, used to cut pollutants from diesel vehicles, which are less popular, particularly in western Europe, after some automakers admitted to cheating in emissions tests.
Things could get worse for platinum. The European diesel-engine market share could halve by 2025, potentially removing 300,000 to 600,000 ounces of platinum demand over the next 10 years, according to Citigroup Inc. Palladium, on the other hand, is expected to remain in deficit, although it will begin to ease over the long term, the bank says.
“Despite the PGM spread inversion since the end of September, we remain favorable to palladium over the short term,” Citigroup analysts including Nell Agate wrote in a note dated Oct. 13. “However, ever-looming substitution risks prevent an outright bullish view on palladium over the long-term.”
https://finance.yahoo.com/news/palladium-tops-1-000-first-062015777.html
U.S. not prepared for a flu pandemic, experts warn.
Posted October 10, 2017 05:21 pm - Updated October 11, 2017 12:06 am
By Tom Corwin Staff Writer, The Augusta Chronicle
As the U.S. begins its annual flu season, experts warn that the country is ill-prepared for a pandemic flu that could cause widespread disruption and death.
In a webinar Tuesday with the Association of Health Care Journalists, flu experts outlined potential problems that will occur if and when there is another flu pandemic. Those occur when there is a large mutation in the current circulating flu viruses that it is unlike previous strains or the emergence of a wholly new kind of strain, often from one that jumps from animals like chickens or pigs to humans, said Dr. Sonja Olsen, deputy chief of the Epidemiology and Prevention Branch in the Flu Division at the Centers for Disease Control and Prevention.
Since 2013, the CDC has been monitoring an avian influenza strain called H7N9 that has caused some human infections, increasing from 135 cases to 759 in the last season that ended in August. About 70 percent of those patients ended up in intensive care units and 40 percent died, she said. However, the virus has not shown yet it can pass very well from human to human, Olsen said.
In an analysis published in recent months, scientists looked carefully at the virus strain and tried to see if it could be made to create certain mutations that would make it more adaptable to humans, known as “gain of function” studies, she said. They noted that it already had some mutations similar to strains that caused pandemics in 1957 and 1968. And that with a few small changes, it could adapt to attack human cells that line the airway, Olsen said.
It “required only a small amount of change to potentially be more devastating in humans,” she said.
The problem with preparing for a pandemic is not so much in the U.S. as it is with other countries whose infrastructure and public health may not be as robust. That is a problem because of the global nature of trade and in particular our reliance on other countries to supply essential drugs and supplies, said Dr. Michael Osterholm, director of the Center for Infectious Disease Research and Policy at the University of Minnesota.
They looked at 30 essential drugs and found that they all are made outside the U.S. except for a couple made in Puerto Rico. Any kind of disruption from a pandemic elsewhere, particularly in India or China, would have a rapid impact on U.S. health care, he said. This is already happening with the devastation in Puerto Rico, which manufactures some drugs for the U.S. already in short supply now, he said. Nor is the U.S. government ready itself to deal with a pandemic, Osterholm said.
“This administration does not have a team in place to deal with that, in my estimation,” he said, though in fairness neither did President Obama. “This is going to take a big team.”
“There are lots of gaps globally,” Olsen said.
Reach Tom Corwin at (706) 823-3213 or tom.corwin@augustachronicle.com
http://chronicle.augusta.com/news/2017-10-10/us-not-prepared-flu-pandemic-experts-warn
Partially reinstate section 936, the Puerto Rican corporate tax code. It will help off set Federal Gov. assistance.
I tweeted to Trump. Maybe somebody picked up on it?
MNGA is doing both. Research and development progress, and has and will mostly continue to buy facilities. CASH BURN, you hit it right on the nose. We will see how much dilution and how much slow down of the cash burn in the next filings. Even though that is not a long term indicator.
Going to be another dilution of one million shares for the next acquisition shortly plus drawing down on their credit line I would imagine and maybe creating some fee dilution as well. My guesstimate, all opinion.
The most positive thing I can admit to is company growth, not to mean financial health. GROWTH is solid.
Been holding a small position in GDI. Looks favorable being that it is a well established company. I am in question to myself of adding more to my position?
Gardner Denver Holdings, Inc. (GDI)
NYSE
https://finance.yahoo.com/quote/GDI?ql=1&p=GDI
Do you think Hugh Hefner went to Heaven?
Never seems to fail. Raising money to raise the Titanic.
I would hunch to opinion that Puerto Rico bond holders are not going to get paid in a timely fashion, even with the Obama oversight board in place.
Note: Hurricane Maria.
Dilution at any price. More coming as long as they keep going it a lone.
Very likely the company had some debri problems like most. Sure there was at least a twig in the parking lot. I had a lot of twigs called branches and roofing. The worse case I would imagine for MNGA was that they might have lost power for a time being. Now I could be wrong and they might of had worse, but I do not think so.
I trust the company fared well, along with all their employees.
My opinion.
Only need $0.27 more to be back in the $1.00 comfort zone.
I like that! Fairy Dust! Good one.
Unreal is correct. $5 stock then dilute.
Good luck! I simply just do not have the initiative to even bother.
Somebody doing a good job manipulating that is obvious to me. Maybe you will get another run to $0.06. One never knows.
My Best!
OPINION
enjoy. not worth it to me. bounce off a dead horse.
Funds exchanging shares? Manipulation would come from wash trading if that was the case, of course high volume can be apart of it. With so many institutions with their hand in TXMD it would be hard to say manipulation is really occurring. Hard judgement. Very confusing.
You just never know what these small research and development companies will come out and say. They needed an excuse for the change in command is my guess.
So all this time the TASE and NASDAQ have existed. Now all of a sudden it will just be the NASDAQ. I do not buy that, because of global exposure. It already has a global exposure plus. If they maybe said it was to eliminate cost of listing on both exchanges. I would have believed the delisting reason a little better.
Well Midas it was a benefit to some of us investors while it lasted meaning when the TASE got active, it would soon spill over to the NASDAQ, generally a day later. Making it a good day trade. Oh well!
OPINION
$4.36 share.
Why would you pick GSK? Just curious!
You act more like a heckler than a responsible shareholder. TXMD just printed a paper which has just excited some investors into buying,
I am not betting on it. I am voicing an opinion of one way it could go being an open minded freedom of speech U.S.A. individual. I prefer to see it follow through all the way to market. If you only knew my history in regards to the flu.
Either way my alternative opinion is great for investors as someone would buy them out regardless of what happens to the product thereafter.
Kill the competition. Remember Edison and Tesla? It happens all the time.
You might never heard of SPEX. The clinical trials all passed. Then by some fool handed political rules. SPEX product which was actually reversed molecular structured sugar was shelved and the company dismantled because of added political rules and a private citizen at last I knew took control of the patent. So nicely dumped, as diabetics ravage America. Kill diabetes and a lot of secondary products go to their grave.
So you get my message?
Buy out! Then buried.
Maybe and maybe not. If governments are involved and I am not just talking the US. The U.S. might be one of the very last to accept it due to the over bearing FDA approval process even though they have a partnership. I would think that Israel would be the leader country and expansion would go from that market after all is said and done. Big pharma could be a plus and or a negative. If the company can make a go of it alone that would be prefered benefit for the world. Big pharma could do what the company might not be able to do alone, that is supply the world at a much faster rate. Big pharma could also bury the product.
That is my opinion.
Simply call the company.
It makes little sense of the selling, but then each investor has their own individuality in regards to selling and or buying. I would have imagined that if you were an investor you would have sold before the split, not after it.
Of course their was a lot of paper out going. Could be agents selling their fee payments. Whatever the reason, sure going to take some healing time. One can only guess going forward. For an investor it would be a personal crime to be buying not having a few quarters of some healthy financials on the record.
Interesting company overall. The final question is will big pharma allow it on the market if it succeeds? You ever think of all the flu suffering remedies on the retail shelves? Not to mention the savings to the general population. Times change and so do the retail product shelves.